LoginGet started
Picture of Kobayashi Pharmaceutical Co logo

4967 — Kobayashi Pharmaceutical Co Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMid CapFalling Star
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Kobayashi Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line26,80426,63527,63627,95027,559
Depreciation
Amortisation
Non-Cash Items153199-276-351-1,052
Unusual Items
Other Non-Cash Items
Changes in Working Capital-10,996-6,956-9,776-1,065-14,204
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities20,08823,98422,41931,89218,360
Capital Expenditures-4,804-4,149-4,185-16,229-13,569
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-268-8,50712,1761,917-6,007
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-5,072-12,6567,991-14,312-19,576
Financing Cash Flow Items-2-230-171-193-240
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-14,581-6,019-10,377-20,759-19,463
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3564,88420,830-2,506-19,789